Opportunities and challenges of incretin-based hypoglycemic agents treating type 2 diabetes mellitus from the perspective of physiological disposition
Yaochen Xie(ZheJiang Institute For Food and Drug Control), Jincheng Wang(Northwestern Polytechnical University), Xiaoyi Wang(Hubei University of Medicine), Qian Zhou(South China Agricultural University), Qiaojun He(Zhejiang Lab)
Cited by 16
Related Papers
Sulforaphane protects against rotenone-induced neurotoxicity in vivo: Involvement of the mTOR, Nrf2 and autophagy pathways
|Scientific Reports|2016|171
Dual regulatory switch through interactions of Tcf7l2/Tcf4 with stage-specific partners propels oligodendroglial maturation
|Nature Communications|2016|166
Discovery of a first-in-class CDK2 selective degrader for AML differentiation therapy
|Nature Chemical Biology|2021|162
Dual-Mode Modulation of Smad Signaling by Smad-Interacting Protein Sip1 Is Required for Myelination in the Central Nervous System
|Neuron|2012|161
Stress Impairs Reconsolidation of Drug Memory via Glucocorticoid Receptors in the Basolateral Amygdala
|Journal of Neuroscience|2008|142